Dr. Shweta Tilara

Dr. Shweta Tilara is a renowned Oncologist practicing in Rajkot for 9 years. Her consultancy and treatment can be availed through appointment from HCG Hospital Rajkot or Star Synergy Hospital, Rajkot. With Degree in DrNB, Medical Oncology and experience of diagnosis and treatment of thousands of patients, she specializes in prevention and treatment of Cancers, Nuclear therapy, Targeted therapy, Immuno therapy, Radio Chemotherapy, Bone Marrow Transplant etc.

Advancements in CAR-NK Cell Therapy: Enhancing Immune Cells for Superior Cancer Targeting

Advancements in CAR-NK Cell Therapy: Enhancing Immune Cells for Superior Cancer Targeting Brazilian researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) have made significant strides in cancer immunotherapy by engineering natural killer (NK) cells to be more potent and precise against tumors. Utilizing the NK-92 cell line, the…

Vitamin D Supplementation Enhances Chemotherapy Response in Breast Cancer

Vitamin D Supplementation Enhances Chemotherapy Response in Breast Cancer: Insights from a Brazilian Study A recent study from the Botucatu School of Medicine at São Paulo State University (FMB-UNESP), Brazil, highlights the potential of low-dose vitamin D supplementation to significantly improve outcomes in breast cancer patients undergoing neoadjuvant chemotherapy. Involving 80 women aged over…

GLP-1 Drug may help in Major Depressive Disorder

### GLP-1 Agonist Semaglutide Shows Promise in Enhancing Motivation for MDD Patients A recent secondary analysis of a randomized controlled trial has revealed that oral semaglutide (Rybelsus), a GLP-1 receptor agonist commonly used in diabetes management, significantly improves motivation in patients with major depressive disorder (MDD) and comorbid overweight or obesity. In the study involving…

Advancements in Cryopreservation: Preventing Cracking in Frozen Transplant Organs

Advancements in Cryopreservation: Preventing Cracking in Frozen Transplant Organs Cryopreservation, the technique of cooling biological tissues to sub-zero temperatures for long-term preservation, has long been a promising yet challenging frontier in medical science. For nearly a century, researchers have worked to refine this process, with significant progress marked in 2023 when scientists at the…

Repurposing DFMO: Treating Rare Genetic Disorders in Children

Repurposing DFMO: A Promising Avenue for Treating Rare Genetic Disorders in Children A decades-old medication, difluoromethylornithine (DFMO or eflornithine), traditionally used for treating West African sleeping sickness, reducing unwanted facial hair in women, and preventing neuroblastoma recurrence, is now showing potential in addressing Bachmann-Bupp syndrome (BABS), an ultra-rare life-threatening genetic disorder. Affecting only about…

What is the dirtiest thing in public bathrooms ?

Public Bathroom Hygiene: Beyond the Toilet Seat – Insights for Infection Prevention Public restrooms pose significant hygiene challenges, particularly for patients with conditions requiring frequent visits, such as diabetes or urinary tract issues, which are prevalent in India. Contrary to common fears, toilet seats are not the primary source of contamination in these facilities….

We are treating Alzheimer’s all wrong

### Rethinking Alzheimer’s Treatment: A Multifactorial Approach for Better Outcomes Alzheimer’s disease (AD) poses a significant challenge in India, where the aging population is rapidly expanding, with over 5 million individuals currently affected and projections estimating a tripling by 2050. Traditional treatments have primarily targeted amyloid-beta (Aβ) plaques, with recent monoclonal antibodies like lecanemab and…

This May Reduce Alzheimer’s risk by 38%

### Lifelong Cognitive Enrichment Linked to Reduced Alzheimer’s Risk: Insights from Recent Neurology Study A recent study published in Neurology, the journal of the American Academy of Neurology, highlights a significant association between lifelong engagement in mentally stimulating activities and a reduced risk of Alzheimer’s disease (AD) and cognitive decline. Researchers from Rush University Medical…

Erythritol: Emerging Concerns on Stroke Risk and Vascular Health

Erythritol: Emerging Concerns on Stroke Risk and Vascular Health Erythritol, a widely used non-nutritive sugar alcohol approved by the FDA in 2001, has gained popularity in India and globally as a low-calorie sweetener in products like sugar-free sodas, keto bars, and low-carb foods. Derived primarily from fermented corn, it offers about 80% of sugar’s…